{
    "organizations": [],
    "uuid": "a3c157dc0f2f6e0f18c6421affe1c3276798a2ae",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-akcea-therapeutics-says-fda-adviso/brief-akcea-therapeutics-says-fda-advisory-committee-meeting-to-review-data-supporting-volanesorsen-nda-idUSFWN1Q51IL",
    "ord_in_thread": 0,
    "title": "BRIEF-Akcea Therapeutics says ‍FDA Advisory Committee Meeting To Review Data Supporting Volanesorsen NDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 15 (Reuters) - Akcea Therapeutics Inc:\n* AKCEA THERAPEUTICS- ‍FDA ADVISORY COMMITTEE MEETING TO REVIEW DATA SUPPORTING VOLANESORSEN NDA; MEETING TENTATIVELY SCHEDULED FOR MAY 10\n* AKCEA THERAPEUTICS INC - ‍ FDA SET A PDUF GOAL DATE OF AUGUST 30, 2018 FOR COMPLETION OF REVIEW​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-16T07:00:00.000+02:00",
    "crawled": "2018-02-16T17:14:45.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "akcea",
        "therapeutic",
        "inc",
        "akcea",
        "advisory",
        "committee",
        "meeting",
        "review",
        "data",
        "supporting",
        "volanesorsen",
        "nda",
        "meeting",
        "tentatively",
        "scheduled",
        "may",
        "akcea",
        "therapeutic",
        "inc",
        "fda",
        "set",
        "pduf",
        "goal",
        "date",
        "august",
        "completion",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}